Fn14-Directed DART Nanoparticles Selectively Target Neoplastic Cells in Preclinical Models of Triple-Negative Breast Cancer Brain Metastasis-Reference-Cited by-同舟云学术

Fn14-Directed DART Nanoparticles Selectively Target Neoplastic Cells in Preclinical Models of Triple-Negative Breast Cancer Brain Metastasis

Published:2022-11-14 Issue:1 Volume:20 Page:314-330
ISSN:1543-8384
Container-title:Molecular Pharmaceutics
language:en
Short-container-title:Mol. Pharmaceutics

Author:

Carney Christine P.¹²,Kapur Anshika¹²,Anastasiadis Pavlos¹²,Ritzel Rodney M.³,Chen Chixiang¹⁴,Woodworth Graeme F.¹²⁵,Winkles Jeffrey A.¹²⁶⁷,Kim Anthony J.¹²⁵⁸⁹^ORCID

Affiliation:

1. Department of Neurosurgery, University of Maryland School of Medicine, Baltimore, Maryland 21201, United States

2. Marlene and Stewart Greenebaum Cancer Center, University of Maryland School of Medicine, Baltimore, Maryland 21201, United States

3. Department of Anesthesiology and Center for Shock, Trauma and Anesthesiology Research (STAR), University of Maryland School of Medicine, Baltimore, Maryland 21201, United States

4. Department of Epidemiology & Public Health, University of Maryland School of Medicine, Baltimore, Maryland 21201, United States

5. Fischell Department of Bioengineering, A. James Clarke School of Engineering, University of Maryland, College Park, Maryland 20742, United States

6. Department of Surgery, University of Maryland School of Medicine, Baltimore, Maryland 21201, United States

7. Center for Vascular and Inflammatory Diseases, University of Maryland School of Medicine, Baltimore, Maryland 21201, United States

8. Department of Pharmacology, University of Maryland School of Medicine, Baltimore, Maryland 21201, United States

9. Department of Pharmaceutical Sciences, University of Maryland School of Pharmacy, Baltimore, Maryland 21201, United States

Funder

U.S. Department of Veterans Affairs

National Institutes of Health

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Pharmaceutical Science,Molecular Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/acs.molpharmaceut.2c00663

Reference90 articles.

1. Reduced cardiotoxicity and comparable efficacy in a phase IIItrial of pegylated liposomal doxorubicin HCl(CAELYX™/Doxil®) versus conventional doxorubicin forfirst-line treatment of metastatic breast cancer

2. Phase III Trial of Nanoparticle Albumin-Bound Paclitaxel Compared With Polyethylated Castor Oil–Based Paclitaxel in Women With Breast Cancer

3. Albumin-bound nanoparticle (nab) paclitaxel exhibits enhanced paclitaxel tissue distribution and tumor penetration

4. Polymeric drugs for efficient tumor-targeted drug delivery based on EPR-effect

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Polymeric nanoparticles as a promising platform for treating triple-negative breast cancer: Current status and future perspectives;International Journal of Pharmaceutics;2024-10

2. Cancer Metastasis‐on‐a‐Chip for Modeling Metastatic Cascade and Drug Screening;Advanced Healthcare Materials;2024-01-26

3. Impact of Targeting Moiety Type and Protein Corona Formation on the Uptake of Fn14-Targeted Nanoparticles by Cancer Cells;ACS Nano;2023-10-09

4. High-throughput single-cell analysis of nanoparticle-cell interactions;TrAC Trends in Analytical Chemistry;2023-09

5. Preclinical models to understand the biology and to discover new targets in brain metastases;Current Opinion in Oncology;2023-06-30